reading identity threads from 2024 and half of it aged badly
Thinking out loud about this: reading identity threads from 2024 and half of it aged badly.
On the thin testing history in this board, and what to do about it.
Most of the compounds discussed here have a handful of independent results across the entire site, and several have none. That is a fact about how few members have paid for testing, not a judgement about the material.
What follows: buy small, test identity first for anything unusual, and post the result even when it is unremarkable. The vendor source pages are built from exactly these submissions, and the compounds with the thinnest coverage are the ones where one more entry changes the picture most. Research material is not approved for human use, so what this board can usefully build is an analytical record.
For any compound with a thin testing history, identity is the first question. Mass spectrometry against a theoretical mass answers it; an area-percent purity figure does not.
Naming in this space is inconsistent. Several widely used names map to more than one molecule, so a catalogue number and a sequence beat a common name every time.
Please do not ask me what dose you should be on. I genuinely do not know and neither does anyone else here.
best — the order this archive was captured in
Stocked lines and made-to-order lines have different lead times and different storage histories. Both are ordinary; the difference is worth confirming before you commit.
Stocked lines and made-to-order lines have different lead times and different storage histories.
isabela_nilsen is right that a purity figure without a method is not comparable to one with a method.
Careful — that is a claim about efficacy and there is essentially no human evidence behind it.
handling and storage vary enormously across this catalogue
Net peptide content on the certificate?
Same. Net peptide content is where the difference between the label and the vial actually shows up.
Storage guidance that names a temperature, a state and a duration reflects actual stability work. Generic guidance usually reflects a template.
Push back: handling advice from one compound does not transfer to another just because both are peptides.
Confirmed the lead time in writing before ordering a made-to-order line. It was longer than the site suggested and entirely reasonable once explained.
identity before purity, every time, for anything unusual
Sent an unusual compound to Medutest because nobody on this site had ever posted one. 98.3% against a claimed 97.5%.
Disagree — that name refers to at least two different molecules depending on who is selling it. The thread needs to be specific.
Disagree — that name refers to at least two different molecules depending on who is selling it.
This is the rule for anything unusual. Identity before anything else.
Disagree — that name refers to at least two different molecules depending on who is selling it.
Adding the practical question — stocked or made to order, and what is the lead time.
Adding the practical question — stocked or made to order, and what is the lead time.
Agreed — and the naming problem is worse than most people here realise.
net peptide content is where the surprises live
I would not treat catalogue breadth as a quality signal. It is a business decision, not an analytical one.
ask which lines are actually stocked rather than made to order
That method was developed for a different compound class and would not resolve the impurities you are asking about.
Catalogue numbers or sequences in posts please — common names are ambiguous in this corner.
the same name covers several different molecules in this space
Ordered under a name that turned out to cover two different molecules. Nobody’s fault but mine for not asking.
Net peptide content on the certificate was well below the purity figure and both were honest. Chemistry, not deception.
Net peptide content on the certificate was well below the purity figure and both were honest.
Disagreeing with this bit: handling for one compound does not transfer to another by default.
Yes. Nothing in this catalogue is approved for human use and the board should keep saying so.
Asked for identity confirmation on an unusual line and got a mass spectrum with the theoretical mass alongside. That is the answer I now look for everywhere.
Bought small on anything without a testing history here. That rule has never once cost me anything.
lead times on unusual lines are the thing to confirm up front
That result is an area percent from an unspecified method, which is not the same as the identity confirmation being discussed.
- 1net peptide content is where the surprises live7 comments in this branch · started by u/reverse_image_ron
- 2Net peptide content on the certificate was well below the purity figure and…6 comments in this branch · started by u/fabio_lehtinen